Nifekalant: A New Option for Pre-Excited Atrial Fibrillation With a High-Risk Accessory Pathway

Atrial fibrillation along with accessory pathway–induced ventricular pre-excitation may be life-threatening due to the high risk of developing severe hypotension, ventricular fibrillation, and sudden death. We demonstrate nifekalant as an effective agent in the pharmacological cardioversion of atria...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Liu, Yu, Liuyu, Chen, Zhijian, Zhang, Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Mini-Focus Issue: Electrophysiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8298543/
https://www.ncbi.nlm.nih.gov/pubmed/34317211
http://dx.doi.org/10.1016/j.jaccas.2019.10.042
_version_ 1783726088079278080
author Yang, Liu
Yu, Liuyu
Chen, Zhijian
Zhang, Min
author_facet Yang, Liu
Yu, Liuyu
Chen, Zhijian
Zhang, Min
author_sort Yang, Liu
collection PubMed
description Atrial fibrillation along with accessory pathway–induced ventricular pre-excitation may be life-threatening due to the high risk of developing severe hypotension, ventricular fibrillation, and sudden death. We demonstrate nifekalant as an effective agent in the pharmacological cardioversion of atrial fibrillation with high-risk accessory pathways. (Level of Difficulty: Intermediate.)
format Online
Article
Text
id pubmed-8298543
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-82985432021-07-26 Nifekalant: A New Option for Pre-Excited Atrial Fibrillation With a High-Risk Accessory Pathway Yang, Liu Yu, Liuyu Chen, Zhijian Zhang, Min JACC Case Rep Mini-Focus Issue: Electrophysiology Atrial fibrillation along with accessory pathway–induced ventricular pre-excitation may be life-threatening due to the high risk of developing severe hypotension, ventricular fibrillation, and sudden death. We demonstrate nifekalant as an effective agent in the pharmacological cardioversion of atrial fibrillation with high-risk accessory pathways. (Level of Difficulty: Intermediate.) Elsevier 2020-02-19 /pmc/articles/PMC8298543/ /pubmed/34317211 http://dx.doi.org/10.1016/j.jaccas.2019.10.042 Text en © 2020 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Mini-Focus Issue: Electrophysiology
Yang, Liu
Yu, Liuyu
Chen, Zhijian
Zhang, Min
Nifekalant: A New Option for Pre-Excited Atrial Fibrillation With a High-Risk Accessory Pathway
title Nifekalant: A New Option for Pre-Excited Atrial Fibrillation With a High-Risk Accessory Pathway
title_full Nifekalant: A New Option for Pre-Excited Atrial Fibrillation With a High-Risk Accessory Pathway
title_fullStr Nifekalant: A New Option for Pre-Excited Atrial Fibrillation With a High-Risk Accessory Pathway
title_full_unstemmed Nifekalant: A New Option for Pre-Excited Atrial Fibrillation With a High-Risk Accessory Pathway
title_short Nifekalant: A New Option for Pre-Excited Atrial Fibrillation With a High-Risk Accessory Pathway
title_sort nifekalant: a new option for pre-excited atrial fibrillation with a high-risk accessory pathway
topic Mini-Focus Issue: Electrophysiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8298543/
https://www.ncbi.nlm.nih.gov/pubmed/34317211
http://dx.doi.org/10.1016/j.jaccas.2019.10.042
work_keys_str_mv AT yangliu nifekalantanewoptionforpreexcitedatrialfibrillationwithahighriskaccessorypathway
AT yuliuyu nifekalantanewoptionforpreexcitedatrialfibrillationwithahighriskaccessorypathway
AT chenzhijian nifekalantanewoptionforpreexcitedatrialfibrillationwithahighriskaccessorypathway
AT zhangmin nifekalantanewoptionforpreexcitedatrialfibrillationwithahighriskaccessorypathway

Ejemplares similares